BlackRock, Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 2012383 New York, NY

Position in GILD

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$16,586,559,291

+$1,465,534,059 QoQ

Shares Held

119,010,973

-3.4% QoQ

Ownership

9.59%

of shares outstanding

% of Portfolio

0.31%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 91.08467166300707.ToString("F0")% Shared 0.ToString("F0")% None 8.915328336992925.ToString("F0")%

Healthcare · as of Mar 31, 2026

BlackRock, Inc. holds $235,197,977,777 across 20 Drug Manufacturers - General names. GILD ranks #5 (7.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	66,380,842	$61,055,107,035
2	JNJ	Johnson & Johnson	213,385,546	$52,159,962,852
3	ABBV	AbbVie Inc.	150,698,125	$32,775,335,197
4	MRK	Merck & Co., Inc.	225,830,330	$27,165,130,383
5	GILD	Gilead Sciences, Inc. This page	119,010,973	$16,586,559,291
6	AMGN	Amgen Inc	47,100,472	$16,572,301,062
7	PFE	Pfizer Inc	498,257,550	$13,991,071,992
8	BMY	Bristol Myers Squibb Co	171,682,888	$10,412,567,149

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$16,586,559,291	119,010,973	-3.4%	Shares	Sole	2026-05-13
2025-12-31	$15,121,025,232	123,195,578	+5.9%	Shares	Sole	2026-02-12
2025-09-30	$12,907,234,401	116,281,391	+1.2%	Shares	Sole	2025-11-12
2025-06-30	$12,736,736,940	114,879,922	-1.1%	Shares	Sole	2025-08-12
2025-03-31	$13,009,517,282	116,104,572	-3.5%	Shares	Sole	2025-05-02
2024-12-31	$11,117,269,021	120,355,841	-1.3%	Shares	Sole	2025-02-07
2024-09-30	$10,223,096,957	121,935,794	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.